TNFSF10 and prostate cancer: Our results showed that combined treatment of TRAIL and taxanes significantly enhanced the apoptotic effect on both subpopulations in PC3 prostate cancer cells compared to TRAIL or taxanes alone, whilst, in DU145 cells, the CSCs were resistant to apoptosis mediated by combination of taxanes and TRAIL.